North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2024-2032
The North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on composition and disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Composition
Mono Vaccines
Combination Vaccines
Market by Disease
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report
1. What was the size of the North America travel vaccines market in 2023?
2. What is the expected growth rate of the North America travel vaccines market during 2024-2032?
3. What are the key factors driving the North America travel vaccines market?
4. What has been the impact of COVID-19 on the North America travel vaccines market?
5. What is the breakup of the North America travel vaccines market based on the composition?
6. What is the breakup of the North America travel vaccines market based on the disease?
7. What are the key regions in the North America travel vaccines market?
Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.
North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on composition and disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Composition
Mono Vaccines
Combination Vaccines
Market by Disease
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report
1. What was the size of the North America travel vaccines market in 2023?
2. What is the expected growth rate of the North America travel vaccines market during 2024-2032?
3. What are the key factors driving the North America travel vaccines market?
4. What has been the impact of COVID-19 on the North America travel vaccines market?
5. What is the breakup of the North America travel vaccines market based on the composition?
6. What is the breakup of the North America travel vaccines market based on the disease?
7. What are the key regions in the North America travel vaccines market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TRAVEL VACCINES MARKET
5.1 Market Performance
5.2 Market Breakup by Composition
5.3 Market Breakup by Disease
5.4 Market Breakup by Region
5.5 Market Forecast
6 NORTH AMERICA TRAVEL VACCINES MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COMPOSITION
7.1 Mono Vaccines
7.2 Combination Vaccines
8 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY DISEASE
8.1 Hepatitis A
8.2 DPT
8.3 Yellow Fever
8.4 Typhoid
8.5 Hepatitis B
8.6 Measles and Mumps
8.7 Rabies
8.8 Meningococcal
8.9 Varicella
8.10 Japanese Encephalitis
8.11 Others
9 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COUNTRY
9.1 United States
9.1.1 Historical Market Trends
9.1.2 Market Breakup by Composition
9.1.3 Market Breakup by Disease
9.1.4 Market Forecast
9.2 Canada
9.2.1 Historical Market Trends
9.2.2 Market Breakup by Composition
9.2.3 Market Breakup by Disease
9.2.4 Market Forecast
9.3 Mexico
9.3.1 Historical Market Trends
9.3.2 Market Breakup by Composition
9.3.3 Market Breakup by Disease
9.3.4 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
11.1 Overview
11.2 Exploratory Stage
11.3 Preclinical and Clinical Development
11.4 Regulatory Approval
11.5 Manufacturing
11.6 Marketing and Distribution
12 PORTER’S FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TRAVEL VACCINES MARKET
5.1 Market Performance
5.2 Market Breakup by Composition
5.3 Market Breakup by Disease
5.4 Market Breakup by Region
5.5 Market Forecast
6 NORTH AMERICA TRAVEL VACCINES MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COMPOSITION
7.1 Mono Vaccines
7.2 Combination Vaccines
8 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY DISEASE
8.1 Hepatitis A
8.2 DPT
8.3 Yellow Fever
8.4 Typhoid
8.5 Hepatitis B
8.6 Measles and Mumps
8.7 Rabies
8.8 Meningococcal
8.9 Varicella
8.10 Japanese Encephalitis
8.11 Others
9 NORTH AMERICA TRAVEL VACCINES MARKET: BREAKUP BY COUNTRY
9.1 United States
9.1.1 Historical Market Trends
9.1.2 Market Breakup by Composition
9.1.3 Market Breakup by Disease
9.1.4 Market Forecast
9.2 Canada
9.2.1 Historical Market Trends
9.2.2 Market Breakup by Composition
9.2.3 Market Breakup by Disease
9.2.4 Market Forecast
9.3 Mexico
9.3.1 Historical Market Trends
9.3.2 Market Breakup by Composition
9.3.3 Market Breakup by Disease
9.3.4 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
11.1 Overview
11.2 Exploratory Stage
11.3 Preclinical and Clinical Development
11.4 Regulatory Approval
11.5 Manufacturing
11.6 Marketing and Distribution
12 PORTER’S FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
